Primary Site >> Esophagus Cancer

Gene >> CDX2

Journal: Am J Clin Pathol. 2005 Sep;124(3):361-70.
Title: CDX2 and MUC2 protein expression in extrahepatic bile duct carcinoma.
Author: Hong, Seung-Mo|Cho, HyungJun|Moskaluk, Christopher A|Frierson, Henry F Jr|Yu, Eunsil|Ro, Jae Y
PMID: 16191504
Journal: Gastroenterology. 2006 Apr;130(4):1191-206.
Title: Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells.
Author: Debruyne, Philip R|Witek, Matthew|Gong, Li|Birbe, Ruth|Chervoneva, Inna|Jin, Tianru|Domon-Cell, Claire|Palazzo, Juan P|Freund, Jean-Noel|Li, Peng|Pitari, Giovanni M|Schulz, Stephanie|Waldman, Scott A
PMID: 16618413
Journal: Dig Liver Dis. 2007 Apr;39(4):305-11. Epub 2007 Feb 16.
Title: COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
Author: Villanacci, V|Rossi, E|Zambelli, C|Galletti, A|Cestari, R|Missale, G|Casa, D Della|Bassotti, G
PMID: 17307036
Journal: Oncol Rep. 2007 Apr;17(4):753-60.
Title: Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma.
Author: Takahashi, Osamu|Hamada, Jun-Ichi|Abe, Motoki|Hata, Shinya|Asano, Toshimichi|Takahashi, Yoko|Tada, Mitsuhiro|Miyamoto, Masaki|Kondo, Satoshi|Moriuchi, Tetsuya
PMID: 17342311
Journal: Int J Cancer. 2007 Sep 15;121(6):1219-26.
Title: Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer.
Author: Guo, MingZhou|House, Michael G|Suzuki, Hiromu|Ye, Ying|Brock, Malcolm V|Lu, Fengmin|Liu, Zhihua|Rustgi, Anil K|Herman, James G
PMID: 17534889
Journal: J Exp Clin Cancer Res. 2009 Aug 7;28:108.
Title: CDX2 hox gene product in a rat model of esophageal cancer.
Author: Ingravallo, Giuseppe|Dall'Olmo, Luigi|Segat, Daniela|Fassan, Matteo|Mescoli, Claudia|Dazzo, Emanuela|Castoro, Carlo|Polimeno, Lorenzo|Rizzetto, Christian|Baroni, Maurizio David|Zaninotto, Giovanni|Ancona, Ermanno|Rugge, Massimo
PMID: 19664209
Journal: Virchows Arch. 2010 Nov;457(5):537-45.
Title: Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus.
Author: Weimann, Andreas|Rieger, Anja|Zimmermann, Mathias|Gross, Monica|Hoffmann, Peter|Slevogt, Hortense|Morawietz, Lars
PMID: 20844891
Journal: Ann Diagn Pathol. 2011 Dec;15(6):450-3.
Title: Combined tubular adenocarcinoma and hepatoid adenocarcinoma arising in Barrett esophagus.
Author: Kuroda, Naoto|Onishi, Kazuhisa|Lee, Gang-Hong
PMID: 20952273
Journal: Hum Pathol. 2012 Nov;43(11):1799-807.
Title: Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping.
Author: DiMaio, Michael A|Kwok, Shirley|Montgomery, Kelli D|Lowe, Anson W|Pai, Reetesh K
PMID: 22748473
Journal: Gastroenterology. 2013 Dec;145(6):1300-11.
Title: Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis.
Author: Matsuzaki, Juntaro|Suzuki, Hidekazu|Tsugawa, Hitoshi|Watanabe, Mitsuhiro|Hossain, Sharif|Arai, Eri|Saito, Yoshimasa|Sekine, Shigeki|Akaike, Toshihiro|Kanai, Yae|Mukaisho, Ken-ichi|Auwerx, Johan|Hibi, Toshifumi
PMID: 23933602